Coronavirus Response

FAQ and what you need to know about the COVID-19 Pandemic

Since the start of the pandemic, Silverberry Genomix has initiated a few projects in response to it. On this page, a list of the projects and collaborations with our partners are listed.

 

Corona Expert App

Looking for a trusted source to stay up to date about the COVID-19 pandemic?

Corona Expert app is created by scientists and experts at Silverberry in partnership with Dana-Farber Research Center, a Harvard Medical School affiliate to provide information to the questions you might have and share the latest research about the novel coronavirus.

Corona Expert also enables you to test your knowledge about the virus.

Download the iOS version of the app from the Apple Store.

The Android version is also in progress and will come soon. subscribe to the below list to be notified when the Android version of the app is available.

[metaslider id="13696"]

Participate in COVID-19 Genomic Study

In response to worldwide COVID-19 outbreak, Silverberry Genomix has launched a genomic study to better understand the current pandemic and improve response to the similar incidences caused by coronaviruses in future.

You can participate in the study by answering a few questions (takes approximately 3 minutes) and include your DNA file for the study. While we are not determining whether you have or been exposed to COVID-19 in the past, your information will help us better understand your possible vulnerability or resistance to it.


COVID-19 Impact Risk Report

Geneticists have turned up intriguing links between DNA and the COVID-19 disease. Some studies suggest that patients with certain types of genetic variation that is also known for predisposition to cognitive decline, seem to be at greater risk and may experience severe illness if infected by the Coronavirus 2 (SARS-CoV-2).

In this report, a DNA file is analyzed for such risk impact assessment.

Learn more

Silverberry Basic Wellness DNa Reports

COVID-19 Diagnostic Testing for Businesses

As our economies slowly re-open for business, we realize that new health protocols need to be implemented into workspaces so that our employees can return to their normal best without having to worry about their safety. Compromising on protecting employees returning to the work is just not an option.

Learn more

Silverberry Basic Wellness DNa Reports

Frequently Asked Questions about the Novel Coronavirus (COVID-19)

As the world copes with the impact of the novel coronavirus (COVID-19) pandemic, we know that you have a lot of questions about what it means for you and the people you care about. At Silverberry, we consider education in the core of activities therefore have gathered the most common questions you might have, about the virus and how best to protect yourself.

If you have any questions that are not answered on this page, email it to faq@silverberrygenomix.com. We will do our best to gather information from experts and post it here. we will continue to update this page to respond to this evolving situation.

 

Protecting yourself and others from COVID-19

What is COVID-19 and how does it spread?

Have More Questions?

What we read

In the times of pandemics, novel ways to care for patients remotely via telemedicine. [link]

Tracking medical supply chain using blockchain [Link]

More than 99% of Italy’s coronavirus fatalities were people who suffered from previous medical conditions [Link]

The Cepheid’s COVID-Test results will be available within 45 minutes, approved by FDA to be released by end of the month. [Link]

Evolution selects for ‘loners’ that hang back from collective behavior—at least in slime molds. [Link]

 

Disclaimer: Silverberry does not offer a diagnostic test, screening, monitoring or any services to cure COVID-19 or any other diseases. Linking to articles does not mean endorsing them. If you experience any COVID-19 virus symptoms, contact your healthcare provider or authorities.  This page and its subpages is for educational purposes only.  See Silverberry Terms of Use and Privacy Policy for more information.